Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells.
about
Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer.Immune cell recruitment and cell-based system for cancer therapy.CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes.Intratracheal delivery of CX3CL1-expressing mesenchymal stem cells to multiple lung tumors.Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential.Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy.Effect of fractalkine-Fc delivery in experimental lung metastasis using DNA/704 nanospheres.Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma.Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironmentCX3CL1 expression is associated with poor outcome in breast cancer patients.CX3CL1/CX3CR1 axis, as The Therapeutic Potential In Renal Diseases: Friend Or Foe?CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy.High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma.Tissue-specific Role of CX3CR1 Expressing Immune Cells and Their Relationships with Human Disease.
P2860
Q35761379-653674F8-82BF-4653-8D0D-E6EC8CFF1881Q36517706-228D3D8C-A994-46F1-96F8-596CECC580D8Q36922514-74DA0E7F-0301-4589-A212-73571DAC4683Q37260900-54FBC571-CC3D-4694-8352-D8BBC7F4DA09Q37670253-4B3733E8-0B2A-47F4-9A1E-7A92D4E1F11CQ38284345-5012AE8A-B010-4F1B-940F-3D9A70CA02DBQ39484211-50777EFF-F612-4076-867D-7F0D23A51761Q41714691-18C6E786-CA4A-4431-B110-404DD158A99BQ42426009-7C17A829-39A7-4713-B79D-A1DB82AD6632Q43501063-0BA99BAC-623D-44FC-9403-BC38C3B55DB6Q49985968-CCFB79FC-84C8-4B18-87E7-44B4299FD9EAQ52718482-F4F04E8F-D2AD-4D27-8C18-D52C2EA75B66Q53383813-45481E36-D89B-4212-9F4C-CBDCE07FD969Q55000062-7EAB1405-6620-40B8-8D41-33A2D34B489A
P2860
Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Antitumor immune response by C ...... epends on both NK and T cells.
@en
type
label
Antitumor immune response by C ...... epends on both NK and T cells.
@en
prefLabel
Antitumor immune response by C ...... epends on both NK and T cells.
@en
P2093
P356
P1476
Antitumor immune response by C ...... epends on both NK and T cells.
@en
P2093
Koichi Hagiwara
Shinya Ohkouchi
Sita Andarini
Takuji Suzuki
Toshiaki Kikuchi
Toshihiro Nukiwa
Yasuo Saijo
P2860
P304
P356
10.1002/EJI.200526042
P407
P50
P577
2005-05-01T00:00:00Z